Jemapete Christopher J 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-03 10:44 am Unchanged |
2022-12-31 | 13G | Gene Biotherapeutics, Inc. CRXM |
Jemapete Christopher J | 4,000,000 6.200% |
0 (Unchanged) |
Filing |
| 2021-04-28 4:20 pm Unchanged |
2021-03-31 | 13G | Gene Biotherapeutics, Inc. CRXM |
Jemapete Christopher J | 4,000,000 8.100% |
0 (Unchanged) |
Filing |
| 2021-03-18 2:05 pm Purchase |
2021-03-16 | 13D | Gene Biotherapeutics, Inc. CRXM |
Jemapete Christopher J | 4,000,000 27.600% |
500,000 (+14.29%) |
Filing |
| 2021-03-01 4:48 pm Purchase |
2021-02-25 | 13D | Gene Biotherapeutics, Inc. CRXM |
Jemapete Christopher J | 3,500,000 24.200% |
3,500,000 (New Position) |
Filing |